{
    "organizations": [],
    "uuid": "fa001bd8289990570cf323683abc82857e99294a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/cipla-results/indias-cipla-posts-q4-profit-idUSL3N1ST3QR",
    "ord_in_thread": 0,
    "title": "India's Cipla posts Q4 profit",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 22 (Reuters) - Cipla Ltd, India’s second-biggest drugmaker by market capitalization, posted a fourth-quarter profit on Tuesday, but missed analysts’ estimates.\nNet profit came in at 1.79 billion rupees ($26.30 million) for the quarter ended March 31, compared with a loss of 617.9 million rupees in the year-ago quarter, the company said here\nAnalysts, on average, had expected a profit of 3.57 billion rupees, according to Thomson Reuters data. ($1 = 68.0650 Indian rupees) (Reporting By Arnab Paul in Bengaluru; Editing by Vyas Mohan)\n ",
    "published": "2018-05-22T18:49:00.000+03:00",
    "crawled": "2018-05-23T15:19:10.041+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "cipla",
        "ltd",
        "india",
        "drugmaker",
        "market",
        "capitalization",
        "posted",
        "profit",
        "tuesday",
        "missed",
        "analyst",
        "estimate",
        "net",
        "profit",
        "came",
        "billion",
        "rupee",
        "million",
        "quarter",
        "ended",
        "march",
        "compared",
        "loss",
        "million",
        "rupee",
        "quarter",
        "company",
        "said",
        "analyst",
        "average",
        "expected",
        "profit",
        "billion",
        "rupee",
        "according",
        "thomson",
        "reuters",
        "data",
        "indian",
        "rupee",
        "reporting",
        "arnab",
        "paul",
        "bengaluru",
        "editing",
        "vyas",
        "mohan"
    ]
}